3h
24/7 Wall St. on MSNWhy Hims & Hers Health (HIMS), Tempus AI (TEM) and Teladoc (TDOC) Are Up Big TodayStock markets got a bit of a shock on Friday after a University of Michigan survey showed consumers are anticipating ...
In a regulatory filing, Tempus AI (TEM) disclosed that COO Ryan Fukushima sold 20,000 shares of the company’s stock. The stock was sold at an ...
1d
24/7 Wall St. on MSNWhy Tempus AI (TEM) Is Soaring TodayUp about 12%, Tempus AI (NASDAQ:TEM) has been explosive. Helping, its volume just spiked to 18.6 million shares, as compared ...
TD Cowen analyst Dan Brennan reinstated coverage of Tempus AI (TEM) with a Buy rating and price target of $74, up from $58, following the ...
Tempus AI has delivered an 82% YTD return, outperforming the broader market and AI-themed stocks amidst market volatility.
Tempus AI's innovative products are transforming the healthcare industry, with a focus on oncology and large market ...
Nvidia (NASDAQ: NVDA) has been the premier AI stock in the past two years. It now has a market cap in the trillions. Nancy Pelosi has seen it coming for a long time. She bought the stock several times ...
We recently published a list of Top 10 AI Stocks Trending On Wall Street. In this article, we are going to take a look at where Tempus AI, Inc.
Coming to the latest development around Olivia, the investors are optimistic, evident from the stock surge last week.
So, when the former Speaker placed a not-insignificant call options wager on TEM stock last month, momentum erupted. Over the trailing one-month period, TEM has gained almost 51% of equity value.
Noting that Ambry is a profitable testing laboratory that generates more than $300 million of revenue annually, the investment bank thinks that the deal will enable TEM to start generating positive ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results